Synta Pharmaceuticals (SNTA) Misses Q1 Loss Views by 2c/Share
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q1 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $660 thousand.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Innovaro (INV) Misses Q2 EPS by 9c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
